Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease

DOI record: { "DOI": "10.1007/s40121-020-00316-3", "ISSN": [ "2193-8229", "2193-6382" ], "URL": "http://dx.doi.org/10.1007/s40121-020-00316-3", "alternative-id": [ "316" ], "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "2 June 2020" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 2, "value": "8 July 2020" } ], "author": [ { "affiliation": [], "family": "Anderson", "given": "Danielle E.", "sequence": "first" }, { "affiliation": [], "family": "Sivalingam", "given": "Velraj", "sequence": "additional" }, { "affiliation": [], "family": "Kang", "given": "Adrian Eng Zheng", "sequence": "additional" }, { "affiliation": [], "family": "Ananthanarayanan", "given": "Abhishek", "sequence": "additional" }, { "affiliation": [], "family": "Arumugam", "given": "Harsha", "sequence": "additional" }, { "affiliation": [], "family": "Jenkins", "given": "Timothy M.", "sequence": "additional" }, { "affiliation": [], "family": "Hadjiat", "given": "Yacine", "sequence": "additional" }, { "affiliation": [], "family": "Eggers", "given": "Maren", "sequence": "additional" } ], "container-title": "Infectious Diseases and Therapy", "container-title-short": "Infect Dis Ther", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2020, 7, 8 ] ], "date-time": "2020-07-08T11:03:42Z", "timestamp": 1594206222000 }, "deposited": { "date-parts": [ [ 2021, 7, 7 ] ], "date-time": "2021-07-07T23:25:07Z", "timestamp": 1625700307000 }, "funder": [ { "name": "Mundipharma Singapore Holding Pte. Limited" } ], "indexed": { "date-parts": [ [ 2024, 5, 7 ] ], "date-time": "2024-05-07T08:34:45Z", "timestamp": 1715070885538 }, "is-referenced-by-count": 128, "issue": "3", "issued": { "date-parts": [ [ 2020, 7, 8 ] ] }, "journal-issue": { "issue": "3", "published-print": { "date-parts": [ [ 2020, 9 ] ] } }, "language": "en", "license": [ { "URL": "https://creativecommons.org/licenses/by-nc/4.0", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 7, 8 ] ], "date-time": "2020-07-08T00:00:00Z", "timestamp": 1594166400000 } }, { "URL": "https://creativecommons.org/licenses/by-nc/4.0", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 7, 8 ] ], "date-time": "2020-07-08T00:00:00Z", "timestamp": 1594166400000 } } ], "link": [ { "URL": "https://link.springer.com/content/pdf/10.1007/s40121-020-00316-3.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/article/10.1007/s40121-020-00316-3/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/content/pdf/10.1007/s40121-020-00316-3.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "page": "669-675", "prefix": "10.1007", "published": { "date-parts": [ [ 2020, 7, 8 ] ] }, "published-online": { "date-parts": [ [ 2020, 7, 8 ] ] }, "published-print": { "date-parts": [ [ 2020, 9 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "key": "316_CR1", "unstructured": "World Health Organisation. WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020: World Health Organisation. 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed 11 May 2020." }, { "DOI": "10.1016/j.ijid.2020.01.050", "author": "S Zhao", "doi-asserted-by": "publisher", "first-page": "214", "journal-title": "Int J Infect Dis.", "key": "316_CR2", "unstructured": "Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 2020;92:214–7.", "volume": "92", "year": "2020" }, { "key": "316_CR3", "unstructured": "Johns Hopkins University and Medicine. Coronavirus Resource Center: John Hopkins University. 2020. https://coronavirus.jhu.edu/map.html. Accessed 22 June 2020." }, { "DOI": "10.1016/bs.aivir.2018.01.001", "author": "VM Corman", "doi-asserted-by": "publisher", "first-page": "163", "journal-title": "Adv Virus Res.", "key": "316_CR4", "unstructured": "Corman VM, Muth D, Niemeyer D, Drosten C. Hosts and sources of endemic human coronaviruses. Adv Virus Res. 2018;100:163–88.", "volume": "100", "year": "2018" }, { "DOI": "10.1056/NEJMoa2001017", "author": "N Zhu", "doi-asserted-by": "publisher", "first-page": "727", "issue": "8", "journal-title": "N Engl J Med.", "key": "316_CR5", "unstructured": "Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.", "volume": "382", "year": "2020" }, { "key": "316_CR6", "unstructured": "World Health Organisation. Interim recommendations on obligatory hand hygiene against transmission of COVID-19: World Health Organization. 2020. https://www.who.int/who-documents-detail/interim-recommendations-on-obligatory-hand-hygiene-against-transmission-of-covid-19. Accessed 18 Apr 2020." }, { "DOI": "10.1016/S2666-5247(20)30003-3", "author": "AWH Chin", "doi-asserted-by": "publisher", "first-page": "e10", "journal-title": "Lancet Microbe.", "key": "316_CR7", "unstructured": "Chin AWH, Chu JTS, Perera MRA, et al. Stability of SARS-CoV-2 in different environmental conditions. Lancet Microbe. 2020;1:e10.", "volume": "1", "year": "2020" }, { "DOI": "10.1007/s40121-017-0172-z", "author": "PM Vogt", "doi-asserted-by": "publisher", "first-page": "545", "issue": "4", "journal-title": "Infect Dis Ther.", "key": "316_CR8", "unstructured": "Vogt PM, Hauser J, Mueller S, Bosse B, Hopp M. Efficacy of conventional and liposomal povidone-iodine in infected mesh skin grafts: an exploratory study. Infect Dis Ther. 2017;6(4):545–55.", "volume": "6", "year": "2017" }, { "DOI": "10.1007/s40121-018-0200-7", "author": "M Eggers", "doi-asserted-by": "publisher", "first-page": "249", "issue": "2", "journal-title": "Infect Dis Ther.", "key": "316_CR9", "unstructured": "Eggers M, Koburger-Janssen T, Eickmann M, Zorn J. In vitro bactericidal and virucidal efficacy of povidone-iodine gargle/mouthwash against respiratory and oral tract pathogens. Infect Dis Ther. 2018;7(2):249–59.", "volume": "7", "year": "2018" }, { "key": "316_CR10", "unstructured": "World Health Organisation. WHO R&D Blueprint COVID 19 Experimental Treatments: World Health Organisation. 2020. https://www.who.int/docs/default-source/coronaviruse/covid-classification-of-treatment-types-rev.pdf. Accessed 18 May 2020." }, { "DOI": "10.1159/000246027", "author": "R Kawana", "doi-asserted-by": "publisher", "first-page": "29", "issue": "Suppl 2", "journal-title": "Dermatology", "key": "316_CR11", "unstructured": "Kawana R, Kitamura T, Nakagomi O, et al. Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology. 1997;195(Suppl 2):29–35.", "volume": "195", "year": "1997" }, { "DOI": "10.1159/000089211", "author": "H Kariwa", "doi-asserted-by": "publisher", "first-page": "119", "issue": "Suppl 1", "journal-title": "Dermatology", "key": "316_CR12", "unstructured": "Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatology. 2006;212(Suppl 1):119–23.", "volume": "212", "year": "2006" }, { "DOI": "10.1007/s40121-015-0091-9", "author": "M Eggers", "doi-asserted-by": "publisher", "first-page": "491", "issue": "4", "journal-title": "Infect Dis Ther.", "key": "316_CR13", "unstructured": "Eggers M, Eickmann M, Zorn J. Rapid and effective virucidal activity of povidone-iodine products against middle east respiratory syndrome coronavirus (MERS-CoV) and modified vaccinia virus Ankara (MVA). Infect Dis Ther. 2015;4(4):491–501.", "volume": "4", "year": "2015" }, { "author": "C Spearman", "first-page": "227", "journal-title": "Br J Psychol.", "key": "316_CR14", "unstructured": "Spearman C. The method of ‘right and wrong cases’ (‘constant stimuli’) without Gauss's formulae. Br J Psychol. 1908;2:227–42.", "volume": "2", "year": "1908" }, { "DOI": "10.1007/BF01863914", "author": "G Kärber", "doi-asserted-by": "publisher", "first-page": "480", "journal-title": "Archiv Exper Pathol Pharmakol.", "key": "316_CR15", "unstructured": "Kärber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Archiv Exper Pathol Pharmakol. 1931;162:480–3.", "volume": "162", "year": "1931" }, { "key": "316_CR16", "unstructured": "Comité Européen de Normalisation. EN14476:2013 + A1:2015: Chemical disinfectants and antiseptics. Quantitative suspension test for the evaluation of virucidal activity in the medical area. Test method and requirements (Phase 2/Step 1) 2015." }, { "author": "M Cascella", "key": "316_CR17", "unstructured": "Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19). Treasure Island, FL: StatPearls; 2020.", "volume-title": "Features, evaluation and treatment coronavirus (COVID-19)", "year": "2020" }, { "DOI": "10.1001/jama.2020.2565", "author": "Y Bai", "doi-asserted-by": "publisher", "first-page": "1406", "issue": "14", "journal-title": "JAMA", "key": "316_CR18", "unstructured": "Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323(14):1406–7.", "volume": "323", "year": "2020" }, { "DOI": "10.3201/eid2607.200282", "author": "S Sanche", "doi-asserted-by": "publisher", "first-page": "1470", "issue": "7", "journal-title": "Emerg Infect Dis", "key": "316_CR19", "unstructured": "Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis. 2020;26(7):1470–7.", "volume": "26", "year": "2020" }, { "DOI": "10.1007/s40121-018-0202-5", "author": "M Eggers", "doi-asserted-by": "publisher", "first-page": "235", "issue": "2", "journal-title": "Infect Dis Ther.", "key": "316_CR20", "unstructured": "Eggers M, Koburger-Janssen T, Ward LS, Newby C, Müller S. Bactericidal and virucidal activity of povidone-iodine and chlorhexidine gluconate cleansers in an in vivo hand hygiene clinical simulation study. Infect Dis Ther. 2018;7(2):235–47.", "volume": "7", "year": "2018" }, { "key": "316_CR21", "unstructured": "Australian Dental Association. Managing COVID-19 Guidelines. 2020. https://www.ada.org.au/Covid-19-Portal/Cards/Dental-Profesionals/Guidelines-and-Risk-Factors/Just-an-information-Card. Accessed 21 June 2020." }, { "key": "316_CR22", "unstructured": "Centers for Disease Control and Prevention. Guidance for dental settings: interim infection prevention and control guidance for dental settings during the COVID-19 response: centers for disease control and prevention. 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/dental-settings.html. Accessed 21 June 2020." }, { "DOI": "10.1159/000057722", "author": "T Nagatake", "doi-asserted-by": "publisher", "first-page": "32", "issue": "Suppl 1", "journal-title": "Dermatology", "key": "316_CR23", "unstructured": "Nagatake T, Ahmed K, Oishi K. Prevention of respiratory lnfections by povidone-lodine gargle. Dermatology. 2002;204(Suppl 1):32–6.", "volume": "204", "year": "2002" }, { "DOI": "10.1038/s41586-020-2196-x", "author": "R Wölfel", "doi-asserted-by": "publisher", "first-page": "465", "issue": "7809", "journal-title": "Nature", "key": "316_CR24", "unstructured": "Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465–9.", "volume": "581", "year": "2020" }, { "DOI": "10.1016/S1473-3099(20)30196-1", "author": "KK To", "doi-asserted-by": "publisher", "first-page": "565", "issue": "5", "journal-title": "Lancet Infect Dis.", "key": "316_CR25", "unstructured": "To KK, Tsang OT, Leung WS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565–74.", "volume": "20", "year": "2020" }, { "author": "D Gui", "first-page": "3438", "issue": "7", "journal-title": "Eur Rev Med Pharmacol Sci.", "key": "316_CR26", "unstructured": "Gui D, Pepe G, Magalini S. Just one more hygiene practice in COVID-19. Eur Rev Med Pharmacol Sci. 2020;24(7):3438–9.", "volume": "24", "year": "2020" }, { "DOI": "10.1093/function/zqaa002", "author": "VB O’Donnell", "doi-asserted-by": "publisher", "first-page": "zqaa002", "journal-title": "Function.", "key": "316_CR27", "unstructured": "O’Donnell VB, Thomas D, Stanton R, et al. Potential role of oral rinses targeting the viral lipid envelope in SARS-CoV-2 infection. Function. 2020;1:zqaa002.", "volume": "1", "year": "2020" }, { "DOI": "10.1016/j.oraloncology.2020.104724", "author": "LJ Mady", "doi-asserted-by": "publisher", "first-page": "104724", "journal-title": "Oral Oncol.", "key": "316_CR28", "unstructured": "Mady LJ, Kubik MW, Baddour K, Snyderman CH, Rowan NR. Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as \"Personal Protective Equipment\" for frontline providers exposed in high-risk head and neck and skull base oncology care. Oral Oncol. 2020;105:104724.", "volume": "105", "year": "2020" }, { "DOI": "10.2139/ssrn.3563092", "doi-asserted-by": "publisher", "key": "316_CR29", "unstructured": "Kirk-Bayley J, Challacombe S, Sunkaraneni S, Combes J. The use of povidone iodine nasal spray and mouthwash during the current COVID-19 pandemic may reduce cross infection and protect healthcare workers. 2020. https://doi.org/10.2139/ssrn.3563092." } ], "reference-count": 29, "references-count": 29, "relation": { "has-preprint": [ { "asserted-by": "object", "id": "10.21203/rs.3.rs-34544/v1", "id-type": "doi" }, { "asserted-by": "object", "id": "10.21203/rs.3.rs-34544/v2", "id-type": "doi" } ] }, "resource": { "primary": { "URL": "https://link.springer.com/10.1007/s40121-020-00316-3" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "volume": "9" }